Lei Deng

Dr. Lei Deng

Hunan provincial key laboratory of medical virology, Institute of Pathogen Biology and Immunology of College of Biology, Hunan University, Changsha 410082, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in IUCrJ
Verified
Journal Article
Open access
PDF file
HZHuiHui Zhang
HuiHui Zhang
PCPei Chen
Pei Chen
HMHaojie Ma
Haojie Ma
MWMagdalena Woińska
Magdalena Woińska
DLDejian Liu
Dejian Liu
HZHeping Zheng
Heping Zheng
Metal binding sites, antigen epitopes and drug binding sites are the hotspots in viral proteins that control how viruses interact with their hosts. virusMED (virus Metal binding sites, Epitopes and Drug binding sites) is a rich internet application based on a database of atomic interactions around hotspots in 7041 experimentally determined viral protein structures. 25306 hotspots from 805 virus strains from 75 virus families were characterized, including influenza, HIV-1 and SARS-CoV-2 viruses. Just as Google Maps organizes and annotates points of interest, virusMED presents the positions of individual hotspots on each viral protein and creates an atlas upon which newly characterized functional sites can be placed as they are being discovered. virusMED contains an extensive set of annotation tags about the virus species and strains, viral hosts, viral proteins, metal ions, specific antibodies and FDA-approved drugs, which permits rapid screening of hotspots on viral proteins tailored to a particular research problem. The virusMED portal (https://virusmed.biocloud.top) can serve as a window to a valuable resource for many areas of virus research and play a critical role in the rational design of new preventative and therapeutic agents targeting viral infections.

7 July 2023 in Cell Reports
Verified
Journal Article
Open access
DLDe-Jian Liu
De-Jian Liu
CLCui-Cui Liu
Cui-Cui Liu
XZXiu-Qin Zhong
Xiu-Qin Zhong
XWXuan Wu
Xuan Wu
HZHui-Hui Zhang
Hui-Hui Zhang
Lei DengLei Deng
Lei Deng
Neuraminidase is suggested as an important component for developing a universal influenza vaccine. Targeted induction of neuraminidase-specific broadly protective antibodies by vaccinations is challenging. To overcome this, we rationally select the highly conserved peptides from the consensus amino acid sequence of the globular head domains of neuraminidase. Inspired by the B cell receptor evolution process, a reliable sequential immunization regimen is designed to result in immuno-focusing by steering bulk immune responses to a selected region where broadly protective B lymphocyte epitopes reside. After priming neuraminidase protein-specific antibody responses in C57BL/6 or BALB/c inbred mice strains by immunization or pre-infection, boost immunizations with certain neuraminidase-derived peptide-keyhole limpet hemocyanin conjugates significantly strengthened serum neuraminidase inhibition activities and cross-protections. Overall, this study provides proof of concept for a peptide-based sequential immunization strategy for achieving targeted induction of cross-protective antibody response, which provides references for designing universal vaccines against other highly variable pathogens.

18 August 2024 in Emerging Microbes & Infections
Verified
Journal Article
Open access
DLDe-Jian Liu
De-Jian Liu
XZXiu-Qin Zhong
Xiu-Qin Zhong
YRYan-Xia Ru
Yan-Xia Ru
SZShi-Long Zhao
Shi-Long Zhao
CLCui-Cui Liu
Cui-Cui Liu
Lei DengLei Deng
Lei Deng
Influenza virus infection poses a continual menace to public health. Here, we developed soluble trimeric HA ectodomain vaccines by establishing interprotomer disulfide bonds in the stem region, which effectively preserve the native antigenicity of stem epitopes. The stable trimeric H1 ectodomain proteins exhibited higher thermal stabilities in comparison with unmodified HAs and showed strong binding activities towards a panel of anti-stem cross-reactive antibodies that recognize either interprotomer or intraprotomer epitopes. Negative stain transmission electron microscopy (TEM) analysis revealed the stable trimer architecture of the interprotomer disulfide-stapled WA11#5, NC99#2, and FLD#1 proteins as well as the irregular aggregation of unmodified HA molecules. Immunizations of mice with those trimeric HA ectodomain vaccines formulated with incomplete Freund's adjuvant elicited significantly more potent cross-neutralizing antibody responses and offered broader immuno-protection against lethal infections with heterologous influenza strains compared to unmodified HA proteins. Additionally, the findings of our study indicate that elevated levels of HA stem-specific antibody responses correlate with strengthened cross-protections. Our design strategy has proven effective in trimerizing HA ectodomains derived from both influenza A and B viruses, thereby providing a valuable reference for designing future influenza HA immunogens.

19 March 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CLCui-Cui Liu
Cui-Cui Liu
YRYan-Xia Ru
Yan-Xia Ru
HLHui-Ru Li
Hui-Ru Li
DLDe-Jian Liu
De-Jian Liu
JLJia-Ye Liu
Jia-Ye Liu
Lei DengLei Deng
Lei Deng

23 September 2022 in Viruses
Verified
Journal Article
Open access
PDF file
CLCui-Cui Liu
Cui-Cui Liu
DLDe-Jian Liu
De-Jian Liu
XYXin-Yu Yue
Xin-Yu Yue
XZXiuqin Zhong
Xiuqin Zhong
XWXuan Wu
Xuan Wu
Lei DengLei Deng
Lei Deng
Influenza virus hemagglutinin (HA) stem is currently regarded as an extremely promising immunogen for designing universal influenza vaccines. The appropriate antigen-presenting vaccine vector would be conducive to increasing the immunogenicity of the HA stem antigen. In this study, we generated chimeric virus-like particles (cVLPs) co-displaying the truncated C-terminal of DnaK from Escherichia coli and H1 stem or full-length H1 antigen using the baculovirus expression system. Transmission electronic micrography revealed the expression and presentation of H1 stem antigens on the surface of VLPs. Vaccinations of mice with the H1 stem cVLPs induced H1-specific immune responses and provided heterologous immune protection in vivo, which was more effective than vaccinations with VLPs displaying H1 stem alone in protecting mice against weight loss as well as increasing survival rates after lethal influenza viral challenge. The results indicate that the incorporation of the truncated C-terminal of DnaK as an adjuvant protein into the cVLPs significantly enhances the H1-specific immunity and immune protection. We have explicitly identified the VLP platform as an effective way of expressing HA stem antigen and revealed that chimeric VLP is an vaccine vector for developing HA stem-based universal influenza vaccines.

17 June 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
USUsman Sagheer
Usman Sagheer
Lei DengLei Deng
Lei Deng